View in EDS

Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.

Saved in:
Bibliographic Details
Title: Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.
Authors: Lachowiez CA; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Heiblig M; Département d'hématologie clinique, Hopital Lyon Sud, Pierre Bénite, France., Aspas Requena G; Service d'hématologie clinique et thérapie cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France., Tavernier-Tardy E; Département d'hématologie clinique, Institut de Cancérologie de Loire, Saint Priest en Jarez, France., Dai F; Hematologics, Inc., Seattle, Washington., Ashango AB; Hematologics, Inc., Seattle, Washington., Peters DT; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Fang J; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., Kaempf A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Long N; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Eide CA; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Kurtz SE; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Xie W; Department of Pathology and Laboratory Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Agarwal A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Sahasrabudhe A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., McMahon CM; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., Amaya ML; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., Meyers G; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Gandhi A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Leonard J; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Hayes-Lattin B; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Maziarz RT; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Traer E; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Cook RJ; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Swords R; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Braun TP; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Saultz JN; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Eckel AM; Hematologics, Inc., Seattle, Washington., Loken MR; Hematologics, Inc., Seattle, Washington., Zeidner JF; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Tyner JW; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado.
Source: Blood cancer discovery [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 437-449.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40396900
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lachowiez+CA%22">Lachowiez CA</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Heiblig+M%22">Heiblig M</searchLink>; Département d'hématologie clinique, Hopital Lyon Sud, Pierre Bénite, France.<br /><searchLink fieldCode="AU" term="%22Aspas+Requena+G%22">Aspas Requena G</searchLink>; Service d'hématologie clinique et thérapie cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Tavernier-Tardy+E%22">Tavernier-Tardy E</searchLink>; Département d'hématologie clinique, Institut de Cancérologie de Loire, Saint Priest en Jarez, France.<br /><searchLink fieldCode="AU" term="%22Dai+F%22">Dai F</searchLink>; Hematologics, Inc., Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Ashango+AB%22">Ashango AB</searchLink>; Hematologics, Inc., Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Peters+DT%22">Peters DT</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Fang+J%22">Fang J</searchLink>; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Kaempf+A%22">Kaempf A</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Long+N%22">Long N</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Eide+CA%22">Eide CA</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Kurtz+SE%22">Kurtz SE</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Xie+W%22">Xie W</searchLink>; Department of Pathology and Laboratory Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Agarwal+A%22">Agarwal A</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Sahasrabudhe+A%22">Sahasrabudhe A</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22McMahon+CM%22">McMahon CM</searchLink>; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Amaya+ML%22">Amaya ML</searchLink>; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Meyers+G%22">Meyers G</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Gandhi+A%22">Gandhi A</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Leonard+J%22">Leonard J</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Hayes-Lattin+B%22">Hayes-Lattin B</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Maziarz+RT%22">Maziarz RT</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Traer+E%22">Traer E</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Cook+RJ%22">Cook RJ</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Swords+R%22">Swords R</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Braun+TP%22">Braun TP</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Saultz+JN%22">Saultz JN</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Eckel+AM%22">Eckel AM</searchLink>; Hematologics, Inc., Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Loken+MR%22">Loken MR</searchLink>; Hematologics, Inc., Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Zeidner+JF%22">Zeidner JF</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Tyner+JW%22">Tyner JW</searchLink>; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Pollyea+DA%22">Pollyea DA</searchLink>; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2025 Sep 03; Vol. 6 (5), pp. 437-449.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40396900
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2643-3230.BCD-24-0256
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 437
    Titles:
      – TitleFull: Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lachowiez CA
      – PersonEntity:
          Name:
            NameFull: Heiblig M
      – PersonEntity:
          Name:
            NameFull: Aspas Requena G
      – PersonEntity:
          Name:
            NameFull: Tavernier-Tardy E
      – PersonEntity:
          Name:
            NameFull: Dai F
      – PersonEntity:
          Name:
            NameFull: Ashango AB
      – PersonEntity:
          Name:
            NameFull: Peters DT
      – PersonEntity:
          Name:
            NameFull: Fang J
      – PersonEntity:
          Name:
            NameFull: Kaempf A
      – PersonEntity:
          Name:
            NameFull: Long N
      – PersonEntity:
          Name:
            NameFull: Eide CA
      – PersonEntity:
          Name:
            NameFull: Kurtz SE
      – PersonEntity:
          Name:
            NameFull: Xie W
      – PersonEntity:
          Name:
            NameFull: Agarwal A
      – PersonEntity:
          Name:
            NameFull: Sahasrabudhe A
      – PersonEntity:
          Name:
            NameFull: McMahon CM
      – PersonEntity:
          Name:
            NameFull: Amaya ML
      – PersonEntity:
          Name:
            NameFull: Meyers G
      – PersonEntity:
          Name:
            NameFull: Gandhi A
      – PersonEntity:
          Name:
            NameFull: Leonard J
      – PersonEntity:
          Name:
            NameFull: Hayes-Lattin B
      – PersonEntity:
          Name:
            NameFull: Maziarz RT
      – PersonEntity:
          Name:
            NameFull: Traer E
      – PersonEntity:
          Name:
            NameFull: Cook RJ
      – PersonEntity:
          Name:
            NameFull: Swords R
      – PersonEntity:
          Name:
            NameFull: Braun TP
      – PersonEntity:
          Name:
            NameFull: Saultz JN
      – PersonEntity:
          Name:
            NameFull: Eckel AM
      – PersonEntity:
          Name:
            NameFull: Loken MR
      – PersonEntity:
          Name:
            NameFull: Zeidner JF
      – PersonEntity:
          Name:
            NameFull: Tyner JW
      – PersonEntity:
          Name:
            NameFull: Pollyea DA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 09
              Text: 2025 Sep 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2643-3249
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Blood cancer discovery
              Type: main
ResultId 1